Skip to content
type1.science
Phase 4RecruitingNCT06021145

Empagliflozin added to AID systems

McGill phase 4 randomized trial testing low-dose empagliflozin added to automated insulin delivery for adults with T1D who are not meeting time-in-range targets.

Primary endpoints

  • Percentage of glucose time in target range

Results so far

No results posted yet.